CASTLEMAN DISEASE
Clinical trials for CASTLEMAN DISEASE explained in plain language.
Never miss a new study
Get alerted when new CASTLEMAN DISEASE trials appear
Sign up with your email to follow new studies for CASTLEMAN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood disorder when standard treatments fail
Disease control OngoingThis study tests whether sirolimus, a medication that targets a specific cell pathway, can help adults with a rare blood disorder called idiopathic multicentric Castleman disease (iMCD) when standard treatments haven't worked. Participants take a daily pill for 12 months to see i…
Matched conditions: CASTLEMAN DISEASE
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: CASTLEMAN DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC